0 التعليقات
0 المشاركات
1كيلو بايت مشاهدة
البحث
إكتشاف أشخاص جدد وإنشاء اتصالات جديدة وصداقات جديدة
-
أخر الأخبار
- استكشف
-
الصفحات
-
المجموعات
-
المدونات
-
المنتديات
-
الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
-
Global Monoclonal Antibodies Market Trends, Demand & Forecast ReportMonoclonal Antibodies Market: According to the latest report published by Data Bridge Market Research, the Monoclonal Antibodies Market Global monoclonal antibodies market size was valued at USD 263.22 billion in 2024 and is projected to reach USD 719.81 billion by 2032, with a CAGR of 13.40% during the forecast period of 2025 to 2032. This Monoclonal Antibodies Market research...0 التعليقات 0 المشاركات 451 مشاهدة
-
Global Pembrolizumab Market Growing at 7.3% CAGR Through 2034According to a new report from Intel Market Research, the global Pembrolizumab market was valued at USD 21.8 billion in 2025 and is projected to grow from USD 24.3 billion in 2026 to USD 42.7 billion by 2034, exhibiting a robust CAGR of 7.3% during the forecast period. This growth is driven by increasing cancer prevalence, rising immunotherapy adoption, expanding regulatory approvals for new...0 التعليقات 0 المشاركات 175 مشاهدة
-
Hyperimmune Globulin Market Opportunities for Biopharma CompaniesThe hyperimmune globulin market is experiencing strong growth due to the rising demand for plasma-derived therapies and increasing awareness regarding immunological treatment solutions. Hyperimmune globulins are highly concentrated antibody products derived from human plasma and are widely used for infection prevention, post-exposure prophylaxis, and immune deficiency treatment. The growing...0 التعليقات 0 المشاركات 545 مشاهدة
-
United States ADC for Solid Tumors Market Growing at 8.9% CAGR Through 2034The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...0 التعليقات 0 المشاركات 373 مشاهدة